2 weeks Ago By ABMN Staff
Susquehanna Portfolio Strategies LLC lowered its stake in Bruker Co. ( NASDAQ:BRKR – Free Report ) by 0.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC.
The institutional investor owned 108,527 shares of the medical research company’s stock after selling 525 shares during the quarter. Susquehanna Portfolio Strategies LLC’s holdings in Bruker were worth $6,925,000 at the end of the most recent reporting period. A number of other institutional investors have also recently bought and sold shares of the stock.
TD Asset Management Inc lifted its stake in Bruker by 7.4% in the first quarter. TD Asset Management Inc now owns 1,788,763 shares of the medical research company’s stock valued at $168,036,000 after buying an additional 123,984 shares in the last quarter.
Congress Asset Management Co. MA lifted its stake in Bruker by 3.5% in the first quarter.
Congress Asset Management Co. MA now owns 1,414,362 shares of the medical research company’s stock valued at $132,865,000 after buying an additional 47,301 shares in the last quarter. Marshall Wace LLP lifted its stake in Bruker by 127.
8% in the second quarter. Marshall Wace LLP now owns 1,389,537 shares of the medical research company’s stock valued at $88,666,000 after buying an additional 779,549 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Bruker by 8.
6% in the second quarter. Dimensional Fund Advisors LP now owns 1,277,273 shares of the medical research company’s stock valued at $81,508,000 after buying an additional 101,539 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Bruker by 3.
0% in the second quarter. Bank of New York Mellon Corp now owns 966,069 shares of the medical research company’s stock valued at $61,645,000 after buying an additional 27,870 shares in the last quarter. Institutional investors own 79.
52% of the company’s stock. Wall Street Analysts Forecast Growth BRKR has been the topic of a number of research reports. TD Cowen cut their price target on shares of Bruker from $74.
00 to $72.00 and set a “hold” rating on the stock in a research note on Wednesday, August 7th. Citigroup lowered their price objective on shares of Bruker from $95.
00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, July 10th. The Goldman Sachs Group lowered their price objective on shares of Bruker from $72.
00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, July 9th. Wells Fargo & Company assumed coverage on shares of Bruker in a report on Tuesday, August 27th.
They set an “overweight” rating and a $78.00 target price on the stock. Finally, Jefferies Financial Group assumed coverage on shares of Bruker in a report on Monday, June 3rd.
They set a “buy” rating and a $85.00 target price on the stock. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company.
Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $81.40. Bruker Trading Up 0.
3 % BRKR stock opened at $70.67 on Friday. The company has a debt-to-equity ratio of 1.
18, a current ratio of 1.65 and a quick ratio of 0.75.
The company has a fifty day moving average price of $65.08 and a two-hundred day moving average price of $72.11.
Bruker Co. has a one year low of $53.79 and a one year high of $94.
86. The stock has a market cap of $10.27 billion, a price-to-earnings ratio of 25.
70, a price-to-earnings-growth ratio of 2.43 and a beta of 1.18.
Bruker ( NASDAQ:BRKR – Get Free Report ) last announced its earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.
52. The company had revenue of $800.70 million during the quarter, compared to analysts’ expectations of $799.
44 million. Bruker had a net margin of 11.29% and a return on equity of 24.
92%. Bruker’s quarterly revenue was up 17.4% on a year-over-year basis.
During the same quarter in the previous year, the business posted $0.50 earnings per share. Equities analysts anticipate that Bruker Co.
will post 2.61 EPS for the current year. Bruker Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Monday, September 16th.
Stockholders of record on Monday, September 2nd were given a $0.05 dividend. The ex-dividend date was Friday, August 30th.
This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.28%.
Bruker’s payout ratio is presently 7.27%. Bruker Company Profile ( Free Report ) Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. See Also Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co.
( NASDAQ:BRKR – Free Report ). Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter .
.
